Author

Peng Su

Nanjing Medical UniversityORCID 0000-0002-7010-8952Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Peng Su2 papers · Columbia University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

Baihong LiiD· 1 shared Fen WangiD· 1 shared Feng LiuiD· 1 shared Feng‐Lai YuaniD· 1 shared Guangyi Huang· 1 shared Haoyu MengiD· 1 shared Jiabao Liu· 1 shared Jiabao YeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Baihong LiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

O-GlcNAcylation-Ubiquitin Crosstalk of METTL1 Drives m7G Epitranscriptomic Collapse and Lipid Metabolic Reprogramming in Diabetic Cardiomyopathy

Xin Gu, Haoyu Meng, Jiabao Liu, Yan Liang, Baihong Li, Fen Wang, Qian S. Liu, Zhixuan Zhang, Jialong Liang, Xiaodong Zhang, Jialong Sun, Jianwei Li, Feng Liu, Xiao Wang, Guangyi Huang, , Yingqiang Du

This study identifies METTL1 O-GlcNAcylation and ubiquitination as key regulators of m7G modification and lipid metabolism in diabetic cardiomyopathy, with a drug targeting this pathway showing therapeutic potential.

bioRxiv · Jul 7, 2025 · PreprintPathology